Medtronic Software Gets FDA OK

摘要

The U.S. Food and Drug Administration (FDA) has approved the use of Medtronic's Lead Integrity Alert (LIA) software to detect problems with the defibrillator lead offerings from its rivals. In a statement, the device giant said LIA software can detect problems in non-Medtronic leads faster than standard impedance monitoring, which entails the measurement of the electrical continuity of a lead four times a day.